BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 004865
(726 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3PEH|A Chain A, Crystal Structure Of The N-Terminal Domain Of An Hsp90
From Plasmodium Falciparum, Pfl1070c In The Presence Of
A Thienopyrimidine Derivative
pdb|3PEH|B Chain B, Crystal Structure Of The N-Terminal Domain Of An Hsp90
From Plasmodium Falciparum, Pfl1070c In The Presence Of
A Thienopyrimidine Derivative
pdb|3PEJ|A Chain A, Crystal Structure Of The N-Terminal Domain Of An Hsp90
From Plasmodium Falciparum, Pfl1070c In The Presence Of
Macbecin
pdb|3PEJ|B Chain B, Crystal Structure Of The N-Terminal Domain Of An Hsp90
From Plasmodium Falciparum, Pfl1070c In The Presence Of
Macbecin
Length = 281
Score = 34.7 bits (78), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 51/114 (44%), Gaps = 21/114 (18%)
Query: 259 IAELVDNSRDA--KATKLEISIESIYFKK--------AGKDIPMLSIIDDGHGMTHQDVV 308
+ EL+ N+ DA K L +S ES+ ++ A K+ +LSI D G GMT D++
Sbjct: 51 LRELISNAADALEKIRFLSLSDESVLGEEKKLEIRISANKEKNILSITDTGIGMTKVDLI 110
Query: 309 R----------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTAD 352
+ D + IG+FGVGF + A + +V T+ D
Sbjct: 111 NNLGTIAKSGTSNFLEAISKSGGDMSLIGQFGVGFYS-AFLVADKVIVYTKNND 163
>pdb|2JKI|A Chain A, Complex Of Hsp90 N-terminal And Sgt1 Cs Domain
pdb|2JKI|B Chain B, Complex Of Hsp90 N-terminal And Sgt1 Cs Domain
pdb|2JKI|C Chain C, Complex Of Hsp90 N-terminal And Sgt1 Cs Domain
Length = 223
Score = 33.5 bits (75), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 34/121 (28%), Positives = 49/121 (40%), Gaps = 20/121 (16%)
Query: 261 ELVDNSRDA----------KATKLEISIESIYFKKAGKDIPMLSIIDDGHGMTHQDVVR- 309
EL+ NS DA +KL+ E K L+I+D G GMT D+V
Sbjct: 41 ELISNSSDALDKIRFESLTDKSKLDAQPELFIHIIPDKATSTLTIVDSGIGMTKSDLVNN 100
Query: 310 --------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFLSQ 361
F D + IG+FGVGF + A + + +V T+ D + SQ
Sbjct: 101 LGTIARSGTKEFMEALAAGADVSMIGQFGVGFYS-AYLVAERVVVTTKHNDDEQYVWESQ 159
Query: 362 S 362
+
Sbjct: 160 A 160
>pdb|2XCM|A Chain A, Complex Of Hsp90 N-Terminal, Sgt1 Cs And Rar1 Chord2
Domain
pdb|2XCM|B Chain B, Complex Of Hsp90 N-Terminal, Sgt1 Cs And Rar1 Chord2
Domain
Length = 214
Score = 33.5 bits (75), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 34/121 (28%), Positives = 49/121 (40%), Gaps = 20/121 (16%)
Query: 261 ELVDNSRDA----------KATKLEISIESIYFKKAGKDIPMLSIIDDGHGMTHQDVVR- 309
EL+ NS DA +KL+ E K L+I+D G GMT D+V
Sbjct: 38 ELISNSSDALDKIRFESLTDKSKLDAQPELFIHIIPDKATSTLTIVDSGIGMTKSDLVNN 97
Query: 310 --------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFLSQ 361
F D + IG+FGVGF + A + + +V T+ D + SQ
Sbjct: 98 LGTIARSGTKEFMEALAAGADVSMIGQFGVGFYS-AYLVAERVVVTTKHNDDEQYVWESQ 156
Query: 362 S 362
+
Sbjct: 157 A 157
>pdb|1U2O|A Chain A, Crystal Structure Of The N-Domain Of Grp94 Lacking The
Charged Domain In Complex With Neca
pdb|1U2O|B Chain B, Crystal Structure Of The N-Domain Of Grp94 Lacking The
Charged Domain In Complex With Neca
pdb|1TBW|A Chain A, Ligand Induced Conformational Shift In The N-Terminal
Domain Of Grp94, Open Conformation
pdb|1TBW|B Chain B, Ligand Induced Conformational Shift In The N-Terminal
Domain Of Grp94, Open Conformation
pdb|1TC0|A Chain A, Ligand Induced Conformational Shifts In The N-Terminal
Domain Of Grp94, Open Conformation Complexed With The
Physiological Partner Atp
pdb|1TC0|B Chain B, Ligand Induced Conformational Shifts In The N-Terminal
Domain Of Grp94, Open Conformation Complexed With The
Physiological Partner Atp
pdb|1TC6|A Chain A, Ligand Induced Conformational Shift In The N-Terminal
Domain Of Grp94, Open Conformation Adp-Complex
pdb|1TC6|B Chain B, Ligand Induced Conformational Shift In The N-Terminal
Domain Of Grp94, Open Conformation Adp-Complex
pdb|1U0Z|A Chain A, N-Domain Of Grp94 Lacking The Charged Domain In Complex
With Radicicol
pdb|1U0Z|B Chain B, N-Domain Of Grp94 Lacking The Charged Domain In Complex
With Radicicol
pdb|1YSZ|A Chain A, Crystal Structure Of The Unliganded Form Of Grp94, The Er
Hsp90: Basis For Nucleotide-Induced Conformational
Change, Grp94n(Delta)41 Apo Crystal Soaked With Neca
pdb|1YT0|A Chain A, Crystal Structure Of The Unliganded Form Of Grp94, The Er
Hsp90: Basis For Nucleotide-Induced Conformational
Change, Grp94n(Delta)41 Apo Crystal Soaked With Adp
pdb|1YT1|A Chain A, Crystal Structure Of The Unliganded Form Of Grp94, The Er
Hsp90: Basis For Nucleotide-Induced Conformational
Change, Grp94n(Delta)41 Apo Crystal
pdb|1YT1|B Chain B, Crystal Structure Of The Unliganded Form Of Grp94, The Er
Hsp90: Basis For Nucleotide-Induced Conformational
Change, Grp94n(Delta)41 Apo Crystal
pdb|2EXL|A Chain A, Grp94 N-Terminal Domain Bound To Geldanamycin
pdb|2EXL|B Chain B, Grp94 N-Terminal Domain Bound To Geldanamycin
pdb|2FYP|A Chain A, Grp94 In Complex With The Novel Hsp90 Inhibitor Radester
Amine
pdb|2FYP|B Chain B, Grp94 In Complex With The Novel Hsp90 Inhibitor Radester
Amine
pdb|2GFD|A Chain A, Grp94 In Complex With The Novel Hsp90 Inhibitor Radamide
pdb|2GFD|B Chain B, Grp94 In Complex With The Novel Hsp90 Inhibitor Radamide
pdb|2GQP|A Chain A, N-Domain Of Grp94 In Complex With The Novel Ligand
N-Propyl Carboxyamido Adenosine
pdb|2GQP|B Chain B, N-Domain Of Grp94 In Complex With The Novel Ligand
N-Propyl Carboxyamido Adenosine
pdb|2HCH|A Chain A, N-Domain Of Grp94 In Complex With The Novel Ligand N-(2-
Amino)ethyl Carboxyamido Adenosine
pdb|2HCH|B Chain B, N-Domain Of Grp94 In Complex With The Novel Ligand N-(2-
Amino)ethyl Carboxyamido Adenosine
pdb|2H8M|A Chain A, N-Domain Of Grp94 In Complex With The 2-Iodo-Neca
pdb|2H8M|B Chain B, N-Domain Of Grp94 In Complex With The 2-Iodo-Neca
pdb|2HG1|A Chain A, N-Domain Of Grp94 In Complex With The Novel Ligand N-(2-
Hydroxyl)ethyl Carboxyamido Adenosine
pdb|2HG1|B Chain B, N-Domain Of Grp94 In Complex With The Novel Ligand N-(2-
Hydroxyl)ethyl Carboxyamido Adenosine
pdb|3O2F|A Chain A, Structure Of The N-Domain Of Grp94 Bound To The Hsp90
Inhibitor Pu-H54
pdb|3O2F|B Chain B, Structure Of The N-Domain Of Grp94 Bound To The Hsp90
Inhibitor Pu-H54
Length = 236
Score = 32.3 bits (72), Expect = 0.99, Method: Compositional matrix adjust.
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 55/215 (25%)
Query: 259 IAELVDNSRDAKATKLEISI---------ESIYFK-KAGKDIPMLSIIDDGHGMTHQDVV 308
+ EL+ N+ DA IS+ E + K K K+ +L + D G GMT +++V
Sbjct: 37 LRELISNASDALDKIRLISLTDENALAGNEELTVKIKCDKEKNLLHVTDTGVGMTREELV 96
Query: 309 R---------MTYFGHKQPDADDPNR-----IGRFGVGFKTGAMRLGKDALVLTQT---- 350
+ + F +K +A + + IG+FGVGF + L D +++T
Sbjct: 97 KNLGTIAKSGTSEFLNKMTEAQEDGQSTSELIGQFGVGFYSAF--LVADKVIVTSKHNND 154
Query: 351 ------ADSRSIAFLS----QSLNQGKDNLEIPIVSYYRKGQFMELDTVVQSEATAKYNL 400
+DS + ++ +L +G I +V ++ELDT+ K +
Sbjct: 155 TQHIWESDSNEFSVIADPRGNTLGRGTT---ITLVLKEEASDYLELDTI-------KNLV 204
Query: 401 KSIKEFSPFNKYLIGEKAGLFQDKCTGTQIYIWNL 435
K +F F Y+ K G G ++ W L
Sbjct: 205 KKYSQFINFPIYVWSSKTG-----GGGKTVWDWEL 234
>pdb|2ESA|A Chain A, Grp94 N-Terminal Domain Bound To Geldanamycin: Effects Of
Mutants 168- 169 Ks-Aa
Length = 236
Score = 32.3 bits (72), Expect = 0.99, Method: Compositional matrix adjust.
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 55/215 (25%)
Query: 259 IAELVDNSRDAKATKLEISI---------ESIYFK-KAGKDIPMLSIIDDGHGMTHQDVV 308
+ EL+ N+ DA IS+ E + K K K+ +L + D G GMT +++V
Sbjct: 37 LRELISNASDALDKIRLISLTDENALAGNEELTVKIKCDKEKNLLHVTDTGVGMTREELV 96
Query: 309 R---------MTYFGHKQPDADDPNR-----IGRFGVGFKTGAMRLGKDALVLTQT---- 350
+ + F +K +A + + IG+FGVGF + L D +++T
Sbjct: 97 KNLGTIAAAGTSEFLNKMTEAQEDGQSTSELIGQFGVGFYSAF--LVADKVIVTSKHNND 154
Query: 351 ------ADSRSIAFLS----QSLNQGKDNLEIPIVSYYRKGQFMELDTVVQSEATAKYNL 400
+DS + ++ +L +G I +V ++ELDT+ K +
Sbjct: 155 TQHIWESDSNEFSVIADPRGNTLGRGTT---ITLVLKEEASDYLELDTI-------KNLV 204
Query: 401 KSIKEFSPFNKYLIGEKAGLFQDKCTGTQIYIWNL 435
K +F F Y+ K G G ++ W L
Sbjct: 205 KKYSQFINFPIYVWSSKTG-----GGGKTVWDWEL 234
>pdb|3K98|A Chain A, Hsp90 N-Terminal Domain In Complex With
(1r)-2-(5-Chloro-2,
4-Dihydroxybenzoyl)-N-Ethylisoindoline-1-Carboxamide
pdb|3K98|B Chain B, Hsp90 N-Terminal Domain In Complex With
(1r)-2-(5-Chloro-2,
4-Dihydroxybenzoyl)-N-Ethylisoindoline-1-Carboxamide
pdb|3K99|A Chain A, Hsp90 N-Terminal Domain In Complex With 4-(1,3-Dihydro-2h-
Isoindol-2-Ylcarbonyl)benzene-1,3-Diol
pdb|3K99|B Chain B, Hsp90 N-Terminal Domain In Complex With 4-(1,3-Dihydro-2h-
Isoindol-2-Ylcarbonyl)benzene-1,3-Diol
pdb|3K99|C Chain C, Hsp90 N-Terminal Domain In Complex With 4-(1,3-Dihydro-2h-
Isoindol-2-Ylcarbonyl)benzene-1,3-Diol
pdb|3K99|D Chain D, Hsp90 N-Terminal Domain In Complex With 4-(1,3-Dihydro-2h-
Isoindol-2-Ylcarbonyl)benzene-1,3-Diol
Length = 232
Score = 32.0 bits (71), Expect = 1.1, Method: Composition-based stats.
Identities = 34/123 (27%), Positives = 52/123 (42%), Gaps = 20/123 (16%)
Query: 259 IAELVDNSRDAKATKLEISIESIYFKKAGKD-----IP-----MLSIIDDGHGMTHQDVV 308
+ EL+ NS DA S+ +GK+ IP L+I+D G GMT D++
Sbjct: 38 LRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLI 97
Query: 309 R---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFL 359
F D + IG+FGVGF + A + + V+T+ D A+
Sbjct: 98 NNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEKVTVITKHNDDEQYAWE 156
Query: 360 SQS 362
S +
Sbjct: 157 SSA 159
>pdb|3EKO|A Chain A, Dihydroxylphenyl Amides As Inhibitors Of The Hsp90
Molecular Chaperone
pdb|3EKO|B Chain B, Dihydroxylphenyl Amides As Inhibitors Of The Hsp90
Molecular Chaperone
pdb|3EKR|A Chain A, Dihydroxylphenyl Amides As Inhibitors Of The Hsp90
Molecular Chaperone
pdb|3EKR|B Chain B, Dihydroxylphenyl Amides As Inhibitors Of The Hsp90
Molecular Chaperone
pdb|3HEK|A Chain A, Hsp90 N-Terminal Domain In Complex With 1-{4-[(2r)-1-(5-
Chloro-2,4-Dihydroxybenzoyl)pyrrolidin-2-Yl]benzyl}-3,3-
Difluoropyrrolidinium
pdb|3HEK|B Chain B, Hsp90 N-Terminal Domain In Complex With 1-{4-[(2r)-1-(5-
Chloro-2,4-Dihydroxybenzoyl)pyrrolidin-2-Yl]benzyl}-3,3-
Difluoropyrrolidinium
pdb|3R4N|A Chain A, Optimization Of Potent, Selective, And Orally Bioavailable
Pyrrolodinopyrimidine-Containing Inhibitors Of Heat
Shock Protein 90. Identification Of Development
Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
4-D]pyrimidine-6-Carboxamide
pdb|3R4N|B Chain B, Optimization Of Potent, Selective, And Orally Bioavailable
Pyrrolodinopyrimidine-Containing Inhibitors Of Heat
Shock Protein 90. Identification Of Development
Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
4-D]pyrimidine-6-Carboxamide
pdb|3R4O|A Chain A, Optimization Of Potent, Selective, And Orally Bioavailable
Pyrrolodinopyrimidine-Containing Inhibitors Of Heat
Shock Protein 90. Identification Of Development
Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
4-D]pyrimidine-6-Carboxamide
pdb|3R4O|B Chain B, Optimization Of Potent, Selective, And Orally Bioavailable
Pyrrolodinopyrimidine-Containing Inhibitors Of Heat
Shock Protein 90. Identification Of Development
Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
4-D]pyrimidine-6-Carboxamide
pdb|3R4P|A Chain A, Optimization Of Potent, Selective, And Orally Bioavailable
Pyrrolodinopyrimidine-Containing Inhibitors Of Heat
Shock Protein 90. Identification Of Development
Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
4-D]pyrimidine-6-Carboxamide
pdb|3R4P|B Chain B, Optimization Of Potent, Selective, And Orally Bioavailable
Pyrrolodinopyrimidine-Containing Inhibitors Of Heat
Shock Protein 90. Identification Of Development
Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
4-D]pyrimidine-6-Carboxamide
pdb|3RLP|A Chain A, Co-Crystal Structure Of The Hsp90 Atp Binding Domain In
Complex With
4-(2,
4-Dichloro-5-Methoxyphenyl)-6-Methylpyrimidin-2-Amine
pdb|3RLP|B Chain B, Co-Crystal Structure Of The Hsp90 Atp Binding Domain In
Complex With
4-(2,
4-Dichloro-5-Methoxyphenyl)-6-Methylpyrimidin-2-Amine
pdb|3RLQ|A Chain A, Co-Crystal Structure Of The Hsp90 Atp Binding Domain In
Complex With
4-(2,4-Dichloro-5-Methoxyphenyl)-2-Methyl-7h-Pyrrolo[2,
3- D]pyrimidine-5- Carbonitrile
pdb|3RLQ|B Chain B, Co-Crystal Structure Of The Hsp90 Atp Binding Domain In
Complex With
4-(2,4-Dichloro-5-Methoxyphenyl)-2-Methyl-7h-Pyrrolo[2,
3- D]pyrimidine-5- Carbonitrile
pdb|3RLR|A Chain A, Co-Crystal Structure Of The Hsp90 Atp Binding Domain In
Complex With
4-(2,4-Dichloro-5-Methoxyphenyl)-2,
6-Dimethyl-7h-Pyrrolo[2,3- D]pyrimidine-5-Carbonitrile
pdb|3RLR|B Chain B, Co-Crystal Structure Of The Hsp90 Atp Binding Domain In
Complex With
4-(2,4-Dichloro-5-Methoxyphenyl)-2,
6-Dimethyl-7h-Pyrrolo[2,3- D]pyrimidine-5-Carbonitrile
Length = 226
Score = 32.0 bits (71), Expect = 1.1, Method: Composition-based stats.
Identities = 34/123 (27%), Positives = 52/123 (42%), Gaps = 20/123 (16%)
Query: 259 IAELVDNSRDAKATKLEISIESIYFKKAGKD-----IP-----MLSIIDDGHGMTHQDVV 308
+ EL+ NS DA S+ +GK+ IP L+I+D G GMT D++
Sbjct: 38 LRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLI 97
Query: 309 R---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFL 359
F D + IG+FGVGF + A + + V+T+ D A+
Sbjct: 98 NNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEKVTVITKHNDDEQYAWE 156
Query: 360 SQS 362
S +
Sbjct: 157 SSA 159
>pdb|3HHU|A Chain A, Human Heat-Shock Protein 90 (Hsp90) In Complex With {4-[3-
(2,4-Dihydroxy-5-Isopropyl-Phenyl)-5-Thioxo-
1,5-Dihydro- [1,2,4]triazol-4-Yl]-Benzyl}-Carbamic Acid
Ethyl Ester {zk 2819}
pdb|3HHU|B Chain B, Human Heat-Shock Protein 90 (Hsp90) In Complex With {4-[3-
(2,4-Dihydroxy-5-Isopropyl-Phenyl)-5-Thioxo-
1,5-Dihydro- [1,2,4]triazol-4-Yl]-Benzyl}-Carbamic Acid
Ethyl Ester {zk 2819}
Length = 224
Score = 32.0 bits (71), Expect = 1.3, Method: Composition-based stats.
Identities = 34/123 (27%), Positives = 52/123 (42%), Gaps = 20/123 (16%)
Query: 259 IAELVDNSRDAKATKLEISIESIYFKKAGKD-----IP-----MLSIIDDGHGMTHQDVV 308
+ EL+ NS DA S+ +GK+ IP L+I+D G GMT D++
Sbjct: 45 LRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLI 104
Query: 309 R---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFL 359
F D + IG+FGVGF + A + + V+T+ D A+
Sbjct: 105 NNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEKVTVITKHNDDEQYAWE 163
Query: 360 SQS 362
S +
Sbjct: 164 SSA 166
>pdb|2O1U|A Chain A, Structure Of Full Length Grp94 With Amp-Pnp Bound
pdb|2O1U|B Chain B, Structure Of Full Length Grp94 With Amp-Pnp Bound
pdb|2O1V|A Chain A, Structure Of Full Length Grp94 With Adp Bound
pdb|2O1V|B Chain B, Structure Of Full Length Grp94 With Adp Bound
Length = 666
Score = 32.0 bits (71), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 55/215 (25%)
Query: 259 IAELVDNSRDAKATKLEISI---------ESIYFK-KAGKDIPMLSIIDDGHGMTHQDVV 308
+ EL+ N+ DA IS+ E + K K K+ +L + D G GMT +++V
Sbjct: 50 LRELISNASDALDKIRLISLTDENALAGNEELTVKIKCDKEKNLLHVTDTGVGMTREELV 109
Query: 309 R---------MTYFGHKQPDADDPNR-----IGRFGVGFKTGAMRLGKDALVLTQT---- 350
+ + F +K +A + + IG+FGVGF + L D +++T
Sbjct: 110 KNLGTIAKSGTSEFLNKMTEAQEDGQSTSELIGQFGVGFYSAF--LVADKVIVTSKHNND 167
Query: 351 ------ADSRSIAFLS----QSLNQGKDNLEIPIVSYYRKGQFMELDTVVQSEATAKYNL 400
+DS + ++ +L +G I +V ++ELDT+ K +
Sbjct: 168 TQHIWESDSNEFSVIADPRGNTLGRG---TTITLVLKEEASDYLELDTI-------KNLV 217
Query: 401 KSIKEFSPFNKYLIGEKAGLFQDKCTGTQIYIWNL 435
K +F F Y+ K G G ++ W L
Sbjct: 218 KKYSQFINFPIYVWSSKTG-----GGGKTVWDWEL 247
>pdb|2K5B|A Chain A, Human Cdc37-Hsp90 Docking Model Based On Nmr
Length = 210
Score = 32.0 bits (71), Expect = 1.3, Method: Composition-based stats.
Identities = 33/123 (26%), Positives = 50/123 (40%), Gaps = 20/123 (16%)
Query: 259 IAELVDNSRDA----------KATKLEISIESIYFKKAGKDIPMLSIIDDGHGMTHQDVV 308
+ EL+ NS DA +KL+ E K L+I+D G GMT D++
Sbjct: 32 LRELISNSSDALDKIRYETLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLI 91
Query: 309 R---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFL 359
F D + IG+FGVGF + A + + V+T+ D A+
Sbjct: 92 NNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEKVTVITKHNDDEQYAWE 150
Query: 360 SQS 362
S +
Sbjct: 151 SSA 153
>pdb|3INW|A Chain A, Hsp90 N-Terminal Domain With Pochoxime A
pdb|3INX|A Chain A, Hsp90 N-Terminal Domain With Pochoxime B
Length = 228
Score = 32.0 bits (71), Expect = 1.3, Method: Composition-based stats.
Identities = 34/123 (27%), Positives = 52/123 (42%), Gaps = 20/123 (16%)
Query: 259 IAELVDNSRDAKATKLEISIESIYFKKAGKD-----IP-----MLSIIDDGHGMTHQDVV 308
+ EL+ NS DA S+ +GK+ IP L+I+D G GMT D++
Sbjct: 37 LRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLI 96
Query: 309 R---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFL 359
F D + IG+FGVGF + A + + V+T+ D A+
Sbjct: 97 NNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEKVTVITKHNDDEQYAWE 155
Query: 360 SQS 362
S +
Sbjct: 156 SSA 158
>pdb|2YI0|A Chain A, Structural Characterization Of
5-Aryl-4-(5-Substituted-2-4-
Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors.
pdb|2YI5|A Chain A, Structural Characterization Of
5-Aryl-4-(5-Substituted-2-4-
Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors.
pdb|2YI6|A Chain A, Structural Characterization Of 5-Aryl-4-(5-Substituted-2-
4-Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors.
pdb|2YI7|A Chain A, Structural Characterization Of
5-Aryl-4-(5-Substituted-2-4-
Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors
Length = 229
Score = 32.0 bits (71), Expect = 1.4, Method: Composition-based stats.
Identities = 34/123 (27%), Positives = 52/123 (42%), Gaps = 20/123 (16%)
Query: 259 IAELVDNSRDAKATKLEISIESIYFKKAGKD-----IP-----MLSIIDDGHGMTHQDVV 308
+ EL+ NS DA S+ +GK+ IP L+I+D G GMT D++
Sbjct: 45 LRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLI 104
Query: 309 R---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFL 359
F D + IG+FGVGF + A + + V+T+ D A+
Sbjct: 105 NNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEKVTVITKHNDDEQYAWE 163
Query: 360 SQS 362
S +
Sbjct: 164 SSA 166
>pdb|1UYI|A Chain A, Human Hsp90-Alpha With
8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-
Pent-9h-Purin-6-Ylamine
Length = 236
Score = 32.0 bits (71), Expect = 1.4, Method: Composition-based stats.
Identities = 34/123 (27%), Positives = 52/123 (42%), Gaps = 20/123 (16%)
Query: 259 IAELVDNSRDAKATKLEISIESIYFKKAGKD-----IP-----MLSIIDDGHGMTHQDVV 308
+ EL+ NS DA S+ +GK+ IP L+I+D G GMT D++
Sbjct: 45 LRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLI 104
Query: 309 R---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFL 359
F D + IG+FGVGF + A + + V+T+ D A+
Sbjct: 105 NNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEKVTVITKHNDDEQYAWE 163
Query: 360 SQS 362
S +
Sbjct: 164 SSA 166
>pdb|3QDD|A Chain A, Hsp90a N-Terminal Domain In Complex With Biib021
Length = 237
Score = 32.0 bits (71), Expect = 1.4, Method: Composition-based stats.
Identities = 32/123 (26%), Positives = 52/123 (42%), Gaps = 20/123 (16%)
Query: 259 IAELVDNSRDAKATKLEISIESIYFKKAGKDIPM----------LSIIDDGHGMTHQDVV 308
+ EL+ NS DA S+ +GK++ + L+I+D G GMT D++
Sbjct: 46 LRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLI 105
Query: 309 R---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFL 359
F D + IG+FGVGF + A + + V+T+ D A+
Sbjct: 106 NNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEKVTVITKHNDDEQYAWE 164
Query: 360 SQS 362
S +
Sbjct: 165 SSA 167
>pdb|1UY6|A Chain A, Human Hsp90-Alpha With
9-Butyl-8-(3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
pdb|1UY7|A Chain A, Human Hsp90-alpha With
9-butyl-8-(4-methoxy-benzyl)-9h-purin-6-ylamine
pdb|1UY8|A Chain A, Human Hsp90-Alpha With
9-Butyl-8-(3-Trimethoxy-Benzyl)-9h-Purin-6ylamine
pdb|1UY9|A Chain A, Human Hsp90-Alpha With
8-Benzo[1,3]dioxol-,
5-Ylmethyl-9-Butyl-9h-Purin-6-Ylamine
pdb|1UYC|A Chain A, Human Hsp90-Alpha With
9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine
pdb|1UYD|A Chain A, Human Hsp90-Alpha With 9-Butyl-8-
(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
pdb|1UYE|A Chain A, Human Hsp90-Alpha With
8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)
-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
pdb|1UYF|A Chain A, Human Hsp90-Alpha With
8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)
-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
pdb|1UYG|A Chain A, Human Hsp90-Alpha With
8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
pdb|1UYH|A Chain A, Human Hsp90-Alpha With 9-Butyl-8-
(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
pdb|1UYK|A Chain A, Human Hsp90-Alpha With
8-Benzo[1,3]dioxol-,5-Ylmethyl-9-But
Yl-2-Fluoro-9h-Purin-6-Ylamine
pdb|1UYL|A Chain A, Structure-Activity Relationships In Purine-Based Inhibitor
Binding To Hsp90 Isoforms
pdb|2UWD|A Chain A, Inhibition Of The Hsp90 Molecular Chaperone In Vitro And
In Vivo By Novel, Synthetic, Potent Resorcinylic
Pyrazole, Isoxazole Amide Analogs
pdb|2VCI|A Chain A, 4,5 Diaryl Isoxazole Hsp90 Chaperone Inhibitors: Potential
Therapeutic Agents For The Treatment Of Cancer
pdb|2VCJ|A Chain A, 4,5 Diaryl Isoxazole Hsp90 Chaperone Inhibitors: Potential
Therapeutic Agents For The Treatment Of Cancer
pdb|2WI1|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
Hsp90 Chaperone
pdb|2WI2|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
Hsp90 Chaperone
pdb|2WI2|B Chain B, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
Hsp90 Chaperone
pdb|2WI3|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
Hsp90 Chaperone
pdb|2WI4|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
Hsp90 Chaperone
pdb|2WI5|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
Hsp90 Chaperone
pdb|2WI6|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
Hsp90 Chaperone
pdb|2WI7|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
Hsp90 Chaperone
pdb|4FCP|A Chain A, Targetting Conserved Water Molecules: Design Of
4-Aryl-5-Cyanopyrrolo [2,3-D] Pyrimidine Hsp90
Inhibitors Using Fragment-Based Screening And
Structure-Based Optimization
pdb|4FCP|B Chain B, Targetting Conserved Water Molecules: Design Of
4-Aryl-5-Cyanopyrrolo [2,3-D] Pyrimidine Hsp90
Inhibitors Using Fragment-Based Screening And
Structure-Based Optimization
pdb|4FCQ|A Chain A, Targeting Conserved Water Molecules: Design Of 4-Aryl-5-
Cyanopyrrolo[2,3-D]pyrimidine Hsp90 Inhibitors Using
Fragment-Based Screening And Structure-Based
Optimization
pdb|4FCR|A Chain A, Targeting Conserved Water Molecules: Design Of 4-Aryl-5-
Cyanopyrrolo[2,3-D]pyrimidine Hsp90 Inhibitors Using
Fragment-Based Screening And Structure-Based
Optimization
Length = 236
Score = 31.6 bits (70), Expect = 1.5, Method: Composition-based stats.
Identities = 32/123 (26%), Positives = 52/123 (42%), Gaps = 20/123 (16%)
Query: 259 IAELVDNSRDAKATKLEISIESIYFKKAGKDIPM----------LSIIDDGHGMTHQDVV 308
+ EL+ NS DA S+ +GK++ + L+I+D G GMT D++
Sbjct: 45 LRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLI 104
Query: 309 R---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFL 359
F D + IG+FGVGF + A + + V+T+ D A+
Sbjct: 105 NNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEKVTVITKHNDDEQYAWE 163
Query: 360 SQS 362
S +
Sbjct: 164 SSA 166
>pdb|2BSM|A Chain A, Novel, Potent Small Molecule Inhibitors Of The Molecular
Chaperone Hsp90 Discovered Through Structure-Based
Design
pdb|2BT0|A Chain A, Novel, Potent Small Molecule Inhibitors Of The Molecular
Chaperone Hsp90 Discovered Through Structure-Based
Design
pdb|2BT0|B Chain B, Novel, Potent Small Molecule Inhibitors Of The Molecular
Chaperone Hsp90 Discovered Through Structure-Based
Design
pdb|2BYH|A Chain A, 3-(5-Chloro-2,4-Dihydroxyphenyl)-Pyrazole-4-Carboxamides
As Inhibitors Of The Hsp90 Molecular Chaperone
pdb|2BYI|A Chain A, 3-(5-Chloro-2,4-Dihydroxyphenyl)-Pyrazole-4-Carboxamides
As Inhibitors Of The Hsp90 Molecular Chaperone
pdb|2BZ5|A Chain A, Structure-Based Discovery Of A New Class Of Hsp90
Inhibitors
pdb|2BZ5|B Chain B, Structure-Based Discovery Of A New Class Of Hsp90
Inhibitors
Length = 235
Score = 31.6 bits (70), Expect = 1.5, Method: Composition-based stats.
Identities = 32/123 (26%), Positives = 52/123 (42%), Gaps = 20/123 (16%)
Query: 259 IAELVDNSRDAKATKLEISIESIYFKKAGKDIPM----------LSIIDDGHGMTHQDVV 308
+ EL+ NS DA S+ +GK++ + L+I+D G GMT D++
Sbjct: 44 LRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLI 103
Query: 309 R---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFL 359
F D + IG+FGVGF + A + + V+T+ D A+
Sbjct: 104 NNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEKVTVITKHNDDEQYAWE 162
Query: 360 SQS 362
S +
Sbjct: 163 SSA 165
>pdb|1U0Y|A Chain A, N-Domain Of Grp94, With The Charged Domain, In Complex
With The Novel Ligand N-Propyl Carboxyamido Adenosine
pdb|1YT2|A Chain A, Crystal Structure Of The Unliganded Form Of Grp94, The Er
Hsp90: Basis For Nucleotide-Induced Conformational
Change, Grp94n Apo Crystal
Length = 273
Score = 31.6 bits (70), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 41/169 (24%), Positives = 73/169 (43%), Gaps = 43/169 (25%)
Query: 259 IAELVDNSRDAKATKLEISI---------ESIYFK-KAGKDIPMLSIIDDGHGMTHQDVV 308
+ EL+ N+ DA IS+ E + K K K+ +L + D G GMT +++V
Sbjct: 37 LRELISNASDALDKIRLISLTDENALAGNEELTVKIKCDKEKNLLHVTDTGVGMTREELV 96
Query: 309 R---------MTYFGHKQPDADDPNR-----IGRFGVGFKTGAMRLGKDALVLTQT---- 350
+ + F +K +A + + IG+FGVGF + L D +++T
Sbjct: 97 KNLGTIAKSGTSEFLNKMTEAQEDGQSTSELIGQFGVGFYSAF--LVADKVIVTSKHNND 154
Query: 351 ------ADSRSIAFLS----QSLNQGKDNLEIPIVSYYRKGQFMELDTV 389
+DS + ++ +L +G I +V ++ELDT+
Sbjct: 155 TQHIWESDSNEFSVIADPRGNTLGRGT---TITLVLKEEASDYLELDTI 200
>pdb|1QY5|A Chain A, Crystal Structure Of The N-Domain Of The Er Hsp90
Chaperone Grp94 In Complex With The Specific Ligand Neca
pdb|1QY8|A Chain A, Crystal Structure Of The N-domain Of The Er Hsp90
Chaperone Grp94 In Complex With Radicicol
pdb|1QYE|A Chain A, Crystal Structure Of The N-domain Of The Er Hsp90
Chaperone Grp94 In Complex With 2-chlorodideoxyadenosine
Length = 269
Score = 31.6 bits (70), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 32/133 (24%), Positives = 59/133 (44%), Gaps = 33/133 (24%)
Query: 285 KAGKDIPMLSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNR-----IGRFG 330
K K+ +L + D G GMT +++V+ + F +K +A + + IG+FG
Sbjct: 69 KCDKEKNLLHVTDTGVGMTREELVKNLGTIAKSGTSEFLNKMTEAQEDGQSTSELIGQFG 128
Query: 331 VGFKTGAMRLGKDALVLTQT----------ADSRSIAFLS----QSLNQGKDNLEIPIVS 376
VGF + L D +++T +DS + ++ +L +G I +V
Sbjct: 129 VGFYSAF--LVADKVIVTSKHNNDTQHIWESDSNEFSVIADPRGNTLGRGT---TITLVL 183
Query: 377 YYRKGQFMELDTV 389
++ELDT+
Sbjct: 184 KEEASDYLELDTI 196
>pdb|1BYQ|A Chain A, Hsp90 N-Terminal Domain Bound To Adp-Mg
pdb|1YER|A Chain A, Human Hsp90 Geldanamycin-Binding Domain, "closed"
Conformation
pdb|1YES|A Chain A, Human Hsp90 Geldanamycin-Binding Domain, "open"
Conformation
pdb|1YET|A Chain A, Geldanamycin Bound To The Hsp90 Geldanamycin-Binding
Domain
Length = 228
Score = 31.6 bits (70), Expect = 1.6, Method: Composition-based stats.
Identities = 33/123 (26%), Positives = 50/123 (40%), Gaps = 20/123 (16%)
Query: 259 IAELVDNSRDA----------KATKLEISIESIYFKKAGKDIPMLSIIDDGHGMTHQDVV 308
+ EL+ NS DA +KL+ E K L+I+D G GMT D++
Sbjct: 37 LRELISNSSDALDKIRYETLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLI 96
Query: 309 R---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFL 359
F D + IG+FGVGF + A + + V+T+ D A+
Sbjct: 97 NNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEKVTVITKHNDDEQYAWE 155
Query: 360 SQS 362
S +
Sbjct: 156 SSA 158
>pdb|2O1W|A Chain A, Structure Of N-Terminal Plus Middle Domains (N+m) Of Grp94
pdb|2O1W|B Chain B, Structure Of N-Terminal Plus Middle Domains (N+m) Of Grp94
pdb|2O1W|C Chain C, Structure Of N-Terminal Plus Middle Domains (N+m) Of Grp94
pdb|2O1W|D Chain D, Structure Of N-Terminal Plus Middle Domains (N+m) Of Grp94
pdb|2O1W|E Chain E, Structure Of N-Terminal Plus Middle Domains (N+m) Of Grp94
Length = 506
Score = 31.6 bits (70), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 55/215 (25%)
Query: 259 IAELVDNSRDAKATKLEISI---------ESIYFK-KAGKDIPMLSIIDDGHGMTHQDVV 308
+ EL+ N+ DA IS+ E + K K K+ +L + D G GMT +++V
Sbjct: 50 LRELISNASDALDKIRLISLTDENALAGNEELTVKIKCDKEKNLLHVTDTGVGMTREELV 109
Query: 309 R---------MTYFGHKQPDADDPNR-----IGRFGVGFKTGAMRLGKDALVLTQT---- 350
+ + F +K +A + + IG+FGVGF + L D +++T
Sbjct: 110 KNLGTIAKSGTSEFLNKMTEAQEDGQSTSELIGQFGVGFYSAF--LVADKVIVTSKHNND 167
Query: 351 ------ADSRSIAFLS----QSLNQGKDNLEIPIVSYYRKGQFMELDTVVQSEATAKYNL 400
+DS + ++ +L +G I +V ++ELDT+ K +
Sbjct: 168 TQHIWESDSNEFSVIADPRGNTLGRGT---TITLVLKEEASDYLELDTI-------KNLV 217
Query: 401 KSIKEFSPFNKYLIGEKAGLFQDKCTGTQIYIWNL 435
K +F F Y+ K G G ++ W L
Sbjct: 218 KKYSQFINFPIYVWSSKTG-----GGGKTVWDWEL 247
>pdb|4GQT|A Chain A, N-Terminal Domain Of C. Elegans Hsp90
pdb|4GQT|B Chain B, N-Terminal Domain Of C. Elegans Hsp90
Length = 227
Score = 31.6 bits (70), Expect = 1.7, Method: Composition-based stats.
Identities = 31/123 (25%), Positives = 51/123 (41%), Gaps = 20/123 (16%)
Query: 259 IAELVDNSRDA----------KATKLEISIESIYFKKAGKDIPMLSIIDDGHGMTHQDVV 308
+ EL+ N+ DA + ++L+ E K+ L+I+D G GMT D+V
Sbjct: 36 LRELISNASDALDKIRYQALTEPSELDTGKELFIKITPNKEEKTLTIMDTGIGMTKADLV 95
Query: 309 R---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFL 359
F D + IG+FGVGF + A + +V ++ D S +
Sbjct: 96 NNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AFLVADKVVVTSKNNDDDSYQWE 154
Query: 360 SQS 362
S +
Sbjct: 155 SSA 157
>pdb|2CCS|A Chain A, Human Hsp90 With
4-Chloro-6-(4-Piperazin-1-Yl-1h-Pyrazol-3-
Yl)-Benzene-1,2-Diol
pdb|2CCT|A Chain A, Human Hsp90 With 5-(5-Chloro-2,4-Dihydroxy-Phenyl)-4-
Piperazin-1-Yl-2h-Pyrazole-3-Carboxylic Acid Ethylamide
pdb|2CCU|A Chain A, Human Hsp90 With 4-Chloro-6-(4-(4-(4-Methanesulphonyl-
Benzyl)-Pierazin-1-Yl)-1h-Pyrazol-3-Yl)-Benzene-1,3-Diol
Length = 236
Score = 31.6 bits (70), Expect = 1.7, Method: Composition-based stats.
Identities = 33/123 (26%), Positives = 50/123 (40%), Gaps = 20/123 (16%)
Query: 259 IAELVDNSRDA----------KATKLEISIESIYFKKAGKDIPMLSIIDDGHGMTHQDVV 308
+ EL+ NS DA +KL+ E K L+I+D G GMT D++
Sbjct: 45 LRELISNSSDALDKIRYETLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLI 104
Query: 309 R---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFL 359
F D + IG+FGVGF + A + + V+T+ D A+
Sbjct: 105 NNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEKVTVITKHNDDEQYAWE 163
Query: 360 SQS 362
S +
Sbjct: 164 SSA 166
>pdb|3NA3|A Chain A, Mutl Protein Homolog 1 Isoform 1 From Homo Sapiens
Length = 348
Score = 31.2 bits (69), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 25/100 (25%), Positives = 49/100 (49%), Gaps = 10/100 (10%)
Query: 258 AIAELVDNSRDAKATKLEISIESIYFKKAGKDIPMLSIIDDGHGMTHQ--DVVRMTYFGH 315
AI E+++N DAK+T +++ + K+ G + ++ I D+G G+ + D+V +
Sbjct: 32 AIKEMIENCLDAKSTSIQVIV-----KEGG--LKLIQIQDNGTGIRKEDLDIVCERFTTS 84
Query: 316 KQPDADDPNRIGRFGV-GFKTGAMRLGKDALVLTQTADSR 354
K +D I +G G ++ + T+TAD +
Sbjct: 85 KLQSFEDLASISTYGFRGEALASISHVAHVTITTKTADGK 124
>pdb|1UYM|A Chain A, Human Hsp90-Beta With Pu3
(9-Butyl-8(3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine)
Length = 220
Score = 30.8 bits (68), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 37/79 (46%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+++D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 83 LTLVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 141
Query: 344 ALVLTQTADSRSIAFLSQS 362
+V+T+ D A+ S +
Sbjct: 142 VVVITKHNDDEQYAWESSA 160
>pdb|3NMQ|A Chain A, Hsp90b N-Terminal Domain In Complex With Ec44, A
Pyrrolo-Pyrimidine Methoxypyridine Inhibitor
Length = 239
Score = 30.8 bits (68), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 37/79 (46%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+++D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 88 LTLVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 146
Query: 344 ALVLTQTADSRSIAFLSQS 362
+V+T+ D A+ S +
Sbjct: 147 VVVITKHNDDEQYAWESSA 165
>pdb|1OSF|A Chain A, Human Hsp90 In Complex With 17-desmethoxy-17-n,n-
Dimethylaminoethylamino-geldanamycin
Length = 215
Score = 30.8 bits (68), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 81 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 139
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 140 VTVITKHNDDEQYAWESSA 158
>pdb|3BM9|A Chain A, Discovery Of Benzisoxazoles As Potent Inhibitors Of
Chaperone Hsp90
pdb|3BMY|A Chain A, Discovery Of Benzisoxazoles As Potent Inhibitors Of
Chaperone Hsp90
pdb|3QTF|A Chain A, Design And Sar Of Macrocyclic Hsp90 Inhibitors With
Increased Metabolic Stability And Potent
Cell-Proliferation Activity
pdb|3R91|A Chain A, Macrocyclic Lactams As Potent Hsp90 Inhibitors With
Excellent Tumor Exposure And Extended Biomarker
Activity.
pdb|3R92|A Chain A, Discovery Of A Macrocyclic O-Aminobenzamide Hsp90
Inhibitor With Heterocyclic Tether That Shows Extended
Biomarker Activity And In Vivo Efficacy In A Mouse
Xenograft Model.
pdb|3RKZ|A Chain A, Discovery Of A Stable Macrocyclic O-Aminobenzamide Hsp90
Inhibitor Capable Of Significantly Decreasing Tumor
Volume In A Mouse Xenograft Model
Length = 226
Score = 30.8 bits (68), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 79 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 137
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 138 VTVITKHNDDEQYAWESSA 156
>pdb|3TUH|A Chain A, Crystal Structure Of The N-Terminal Domain Of An Hsp90 In
The Presence Of An The Inhibitor Ganetespib
pdb|3TUH|B Chain B, Crystal Structure Of The N-Terminal Domain Of An Hsp90 In
The Presence Of An The Inhibitor Ganetespib
Length = 209
Score = 30.8 bits (68), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 74 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 132
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 133 VTVITKHNDDEQYAWESSA 151
>pdb|3K97|A Chain A, Hsp90 N-Terminal Domain In Complex With
4-Chloro-6-{[(2r)-2-
(2-Methylphenyl)pyrrolidin-1-Yl]carbonyl}benzene-1,
3-Diol
Length = 251
Score = 30.8 bits (68), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 104 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 162
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 163 VTVITKHNDDEQYAWESSA 181
>pdb|2QFO|A Chain A, Hsp90 Complexed With A143571 And A516383
pdb|2QFO|B Chain B, Hsp90 Complexed With A143571 And A516383
pdb|2QG0|A Chain A, Hsp90 Complexed With A943037
pdb|2QG0|B Chain B, Hsp90 Complexed With A943037
Length = 207
Score = 30.8 bits (68), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 73 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 131
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 132 VTVITKHNDDEQYAWESSA 150
>pdb|2QF6|A Chain A, Hsp90 Complexed With A56322
pdb|2QF6|B Chain B, Hsp90 Complexed With A56322
pdb|2QF6|C Chain C, Hsp90 Complexed With A56322
pdb|2QF6|D Chain D, Hsp90 Complexed With A56322
pdb|2QG2|A Chain A, Hsp90 Complexed With A917985
pdb|3OW6|A Chain A, Crystal Structure Of Hsp90 With N-Aryl-Benzimidazolone I
pdb|3OWB|A Chain A, Crystal Structure Of Hsp90 With Ver-49009
pdb|3OWD|A Chain A, Crystal Structure Of Hsp90 With N-Aryl-Benzimidazolone Ii
Length = 207
Score = 30.8 bits (68), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 73 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 131
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 132 VTVITKHNDDEQYAWESSA 150
>pdb|3D0B|A Chain A, Crystal Structure Of Benzamide
Tetrahydro-4h-Carbazol-4-One Bound To Hsp90
pdb|3MNR|P Chain P, Crystal Structure Of Benzamide Snx-1321 Bound To Hsp90
Length = 232
Score = 30.8 bits (68), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 89 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 147
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 148 VTVITKHNDDEQYAWESSA 166
>pdb|4AWO|A Chain A, Complex Of Hsp90 Atpase Domain With Tropane Derived
Inhibitors
pdb|4AWO|B Chain B, Complex Of Hsp90 Atpase Domain With Tropane Derived
Inhibitors
pdb|4AWP|A Chain A, Complex Of Hsp90 Atpase Domain With Tropane Derived
Inhibitors
pdb|4AWP|B Chain B, Complex Of Hsp90 Atpase Domain With Tropane Derived
Inhibitors
pdb|4AWQ|A Chain A, Complex Of Hsp90 Atpase Domain With Tropane Derived
Inhibitors
pdb|4AWQ|B Chain B, Complex Of Hsp90 Atpase Domain With Tropane Derived
Inhibitors
Length = 230
Score = 30.8 bits (68), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 83 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 141
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 142 VTVITKHNDDEQYAWESSA 160
>pdb|3R4M|A Chain A, Optimization Of Potent, Selective, And Orally Bioavailable
Pyrrolodinopyrimidine-Containing Inhibitors Of Heat
Shock Protein 90. Identification Of Development
Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
4-D]pyrimidine-6-Carboxamide
pdb|3T0H|A Chain A, Structure Insights Into Mechanisms Of Atp Hydrolysis And
The Activation Of Human Hsp90
pdb|3T0Z|A Chain A, Hsp90 N-Terminal Domain Bound To Atp
pdb|3T10|A Chain A, Hsp90 N-Terminal Domain Bound To Acp
pdb|3T1K|A Chain A, Hsp90 N-Terminal Domain Bound To Anp
pdb|3T1K|B Chain B, Hsp90 N-Terminal Domain Bound To Anp
pdb|3T2S|A Chain A, Hsp90 N-Terminal Domain Bound To Ags
pdb|3T2S|B Chain B, Hsp90 N-Terminal Domain Bound To Ags
Length = 228
Score = 30.8 bits (68), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 81 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 139
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 140 VTVITKHNDDEQYAWESSA 158
>pdb|3B24|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An
Aminotriazine Fragment Molecule
pdb|3B24|B Chain B, Hsp90 Alpha N-Terminal Domain In Complex With An
Aminotriazine Fragment Molecule
pdb|3B25|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor
Ch4675194
pdb|3B26|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor
Ro1127850
pdb|3B26|B Chain B, Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor
Ro1127850
pdb|3B27|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor
Ro4919127
pdb|3B28|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor
Ch5015765
pdb|3B28|B Chain B, Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor
Ch5015765
pdb|3VHA|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With A
Macrocyclic Inhibitor
pdb|3VHC|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With A
Macrocyclic Inhibitor
pdb|3VHD|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With A
Macrocyclic Inhibitor, Ch5164840
pdb|3VHD|B Chain B, Hsp90 Alpha N-Terminal Domain In Complex With A
Macrocyclic Inhibitor, Ch5164840
Length = 229
Score = 30.8 bits (68), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 82 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 140
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 141 VTVITKHNDDEQYAWESSA 159
>pdb|2JJC|A Chain A, Hsp90 Alpha Atpase Domain With Bound Small Molecule
Fragment
Length = 218
Score = 30.8 bits (68), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 84 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 142
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 143 VTVITKHNDDEQYAWESSA 161
>pdb|4EEH|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor
3-(4- Hydroxy-Phenyl)-1h-Indazol-6-Ol
pdb|4EFT|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor
3-
Cyclohexyl-2-(6-Hydroxy-1h-Indazol-3-Yl)-Propionitrile
pdb|4EFU|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor
6-Hydroxy- 3-(3-Methyl-Benzyl)-1h-Indazole-5-Carboxylic
Acid Benzyl-Methyl-Amide
Length = 229
Score = 30.4 bits (67), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 82 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 140
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 141 VTVITKHNDDEQYAWESSA 159
>pdb|4EGH|A Chain A, Hsp90-Alpha Atpase Domain In Complex With
(4-Hydroxyphenyl)morpholin- 4-Yl Methanone
pdb|4EGI|A Chain A, Hsp90-Alpha Atpase Domain In Complex With
2-Amino-4-Ethylthio-6- Methyl-1,3,5-Triazine
pdb|4EGK|A Chain A, Human Hsp90-Alpha Atpase Domain Bound To Radicicol
Length = 232
Score = 30.4 bits (67), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 85 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 143
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 144 VTVITKHNDDEQYAWESSA 162
>pdb|2XDU|A Chain A, Structre Of Hsp90 With Small Molecule Inhibitor Bound
Length = 236
Score = 30.4 bits (67), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 101 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 159
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 160 VTVITKHNDDEQYAWESSA 178
>pdb|2YJW|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
pdb|2YJX|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
pdb|2YK2|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
pdb|2YKB|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
pdb|2YKC|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
pdb|2YKE|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
pdb|2YKI|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
pdb|2YKJ|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
pdb|2YK9|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
Length = 209
Score = 30.4 bits (67), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 75 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 133
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 134 VTVITKHNDDEQYAWESSA 152
>pdb|3FT5|A Chain A, Structure Of Hsp90 Bound With A Novel Fragment
pdb|3FT8|A Chain A, Structure Of Hsp90 Bound With A Noval Fragment.
pdb|3HYY|A Chain A, Crystal Structure Of Hsp90 With Fragment 37-D04
pdb|3HYZ|A Chain A, Crystal Structure Of Hsp90 With Fragment 42-C03
pdb|3HYZ|B Chain B, Crystal Structure Of Hsp90 With Fragment 42-C03
pdb|3HZ1|A Chain A, Crystal Structure Of Hsp90 With Fragments 37-D04 And
42-C03
pdb|3HZ5|A Chain A, Crystal Structure Of Hsp90 With Fragment Z064
pdb|2XAB|A Chain A, Structure Of Hsp90 With An Inhibitor Bound
pdb|2XAB|B Chain B, Structure Of Hsp90 With An Inhibitor Bound
pdb|2XJX|A Chain A, Structre Of Hsp90 With Small Molecule Inhibitor Bound
pdb|2XDK|A Chain A, Structure Of Hsp90 With Small Molecule Inhibitor Bound
pdb|2XDL|A Chain A, Structure Of Hsp90 With Small Molecule Inhibitor Bound
pdb|2XDS|A Chain A, Structre Of Hsp90 With Small Molecule Inhibitor Bound
pdb|2XDX|A Chain A, Structre Of Hsp90 With Small Molecule Inhibitor Bound
pdb|2XHR|A Chain A, Structure Of Hsp90 With Small Molecule Inhibitor Bound
pdb|2XHT|A Chain A, Structure Of Hsp90 With Small Molecule Inhibitor Bound
pdb|2XK2|A Chain A, Structre Of Hsp90 With Small Molecule Inhibitor Bound
Length = 249
Score = 30.4 bits (67), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 102 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 160
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 161 VTVITKHNDDEQYAWESSA 179
>pdb|2XJG|A Chain A, Structure Of Hsp90 With Small Molecule Inhibitor Bound
pdb|2XHX|A Chain A, Structure Of Hsp90 With Small Molecule Inhibitor Bound
Length = 249
Score = 30.4 bits (67), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 102 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 160
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 161 VTVITKHNDDEQYAWESSA 179
>pdb|2FWY|A Chain A, Structure Of Human Hsp90-Alpha Bound To The Potent Water
Soluble Inhibitor Pu-H64
pdb|2FWZ|A Chain A, Structure Of Human Hsp90-alpha Bound To The Potent Water
Soluble Inhibitor Pu-h71
pdb|2H55|A Chain A, Structure Of Human Hsp90-Alpha Bound To The Potent Water
Soluble Inhibitor Pu-Dz8
pdb|3O0I|A Chain A, Structure Of The Human Hsp90-Alpha N-Domain Bound To The
Hsp90 Inhibitor Pu-H54
Length = 256
Score = 30.4 bits (67), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 109 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 167
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 168 VTVITKHNDDEQYAWESSA 186
>pdb|1YC1|A Chain A, Crystal Structures Of Human Hsp90alpha Complexed With
Dihydroxyphenylpyrazoles
pdb|1YC3|A Chain A, Crystal Structure Of Human Hsp90alpha Complexed With
Dihydroxyphenylpyrazoles
pdb|1YC4|A Chain A, Crystal Structure Of Human Hsp90alpha Complexed With
Dihydroxyphenylpyrazoles
Length = 264
Score = 30.4 bits (67), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 117 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 175
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 176 VTVITKHNDDEQYAWESSA 194
>pdb|2YE2|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YE3|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YE4|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YE5|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YE6|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YE9|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YEA|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YEB|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YEC|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YED|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YEF|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YEG|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YEG|B Chain B, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YEH|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
Length = 252
Score = 30.4 bits (67), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 105 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 163
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 164 VTVITKHNDDEQYAWESSA 182
>pdb|2YE7|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YE8|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YEI|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YEJ|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
Length = 252
Score = 30.0 bits (66), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 105 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 163
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 164 VTVITKHNDDEQYAWESSA 182
>pdb|2YEE|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
Length = 252
Score = 30.0 bits (66), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 105 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 163
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 164 VTVITKHNDDEQYAWESSA 182
>pdb|1H7S|A Chain A, N-Terminal 40kda Fragment Of Human Pms2
pdb|1H7S|B Chain B, N-Terminal 40kda Fragment Of Human Pms2
Length = 365
Score = 30.0 bits (66), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 22/75 (29%), Positives = 39/75 (52%), Gaps = 9/75 (12%)
Query: 258 AIAELVDNSRDAKATKLEISIESIYFKKAGKDIPMLSIIDDGHGMTHQDVVRMTYFGH-- 315
A+ ELV+NS DA AT +++ + K G D ++ + D+G G+ ++ +T H
Sbjct: 38 AVKELVENSLDAGATNIDLKL-----KDYGVD--LIEVSDNGCGVEEENFEGLTLKHHTS 90
Query: 316 KQPDADDPNRIGRFG 330
K + D ++ FG
Sbjct: 91 KIQEFADLTQVETFG 105
>pdb|1H7U|A Chain A, Hpms2-atpgs
pdb|1H7U|B Chain B, Hpms2-atpgs
Length = 365
Score = 30.0 bits (66), Expect = 5.3, Method: Compositional matrix adjust.
Identities = 22/75 (29%), Positives = 39/75 (52%), Gaps = 9/75 (12%)
Query: 258 AIAELVDNSRDAKATKLEISIESIYFKKAGKDIPMLSIIDDGHGMTHQDVVRMTYFGH-- 315
A+ ELV+NS DA AT +++ + K G D ++ + D+G G+ ++ +T H
Sbjct: 38 AVKELVENSLDAGATNIDLKL-----KDYGVD--LIEVSDNGCGVEEENFEGLTLKHHTS 90
Query: 316 KQPDADDPNRIGRFG 330
K + D ++ FG
Sbjct: 91 KIQEFADLTQVETFG 105
>pdb|1BKN|A Chain A, Crystal Structure Of An N-Terminal 40kd Fragment Of E.
Coli Dna Mismatch Repair Protein Mutl
pdb|1BKN|B Chain B, Crystal Structure Of An N-Terminal 40kd Fragment Of E.
Coli Dna Mismatch Repair Protein Mutl
Length = 352
Score = 30.0 bits (66), Expect = 5.4, Method: Compositional matrix adjust.
Identities = 39/159 (24%), Positives = 70/159 (44%), Gaps = 14/159 (8%)
Query: 259 IAELVDNSRDAKATKLEISIESIYFKKAGKDIPMLSIIDDGHGMTHQDVVRMTYFGH--- 315
+ ELV+NS DA AT+++I IE + G ++ I D+G G+ +D + + H
Sbjct: 30 VKELVENSLDAGATRIDIDIE-----RGGAK--LIRIRDNGCGIK-KDELALALARHATS 81
Query: 316 KQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFLSQSLNQGKD-NLEIPI 374
K DD I +GF+ A+ LT T+ + Q+ +G+D N+ +
Sbjct: 82 KIASLDDLEAI--ISLGFRGEALASISSVSRLTLTSRTAEQQEAWQAYAEGRDMNVTVKP 139
Query: 375 VSYYRKGQFMELDTVVQSEATAKYNLKSIKEFSPFNKYL 413
++ LD + A K+ EF+ ++ +
Sbjct: 140 AAHPVGTTLEVLDLFYNTPARRKFLRTEKTEFNHIDEII 178
>pdb|1EA6|A Chain A, N-Terminal 40kda Fragment Of Nhpms2 Complexed With Adp
pdb|1EA6|B Chain B, N-Terminal 40kda Fragment Of Nhpms2 Complexed With Adp
Length = 364
Score = 29.6 bits (65), Expect = 5.5, Method: Compositional matrix adjust.
Identities = 22/75 (29%), Positives = 39/75 (52%), Gaps = 9/75 (12%)
Query: 258 AIAELVDNSRDAKATKLEISIESIYFKKAGKDIPMLSIIDDGHGMTHQDVVRMTYFGH-- 315
A+ ELV+NS DA AT +++ + K G D ++ + D+G G+ ++ +T H
Sbjct: 38 AVKELVENSLDAGATNIDLKL-----KDYGVD--LIEVSDNGCGVEEENFEGLTLKHHTS 90
Query: 316 KQPDADDPNRIGRFG 330
K + D ++ FG
Sbjct: 91 KIQEFADLTQVETFG 105
>pdb|1B62|A Chain A, Mutl Complexed With Adp
Length = 355
Score = 29.6 bits (65), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 39/159 (24%), Positives = 70/159 (44%), Gaps = 14/159 (8%)
Query: 259 IAELVDNSRDAKATKLEISIESIYFKKAGKDIPMLSIIDDGHGMTHQDVVRMTYFGH--- 315
+ ELV+NS DA AT+++I IE + G ++ I D+G G+ +D + + H
Sbjct: 33 VKELVENSLDAGATRIDIDIE-----RGGAK--LIRIRDNGCGIK-KDELALALARHATS 84
Query: 316 KQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFLSQSLNQGKD-NLEIPI 374
K DD I +GF+ A+ LT T+ + Q+ +G+D N+ +
Sbjct: 85 KIASLDDLEAI--ISLGFRGEALASISSVSRLTLTSRTAEQQEAWQAYAEGRDMNVTVKP 142
Query: 375 VSYYRKGQFMELDTVVQSEATAKYNLKSIKEFSPFNKYL 413
++ LD + A K+ EF+ ++ +
Sbjct: 143 AAHPVGTTLEVLDLFYNTPARRKFLRTEKTEFNHIDEII 181
>pdb|1B63|A Chain A, Mutl Complexed With Adpnp
pdb|1NHH|A Chain A, Crystal Structure Of N-Terminal 40kd Mutl Protein (Ln40)
Complex With Adpnp And One Rubidium
pdb|1NHI|A Chain A, Crystal Structure Of N-Terminal 40kd Mutl (Ln40) Complex
With Adpnp And One Potassium
Length = 333
Score = 29.6 bits (65), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 39/159 (24%), Positives = 70/159 (44%), Gaps = 14/159 (8%)
Query: 259 IAELVDNSRDAKATKLEISIESIYFKKAGKDIPMLSIIDDGHGMTHQDVVRMTYFGH--- 315
+ ELV+NS DA AT+++I IE + G ++ I D+G G+ +D + + H
Sbjct: 29 VKELVENSLDAGATRIDIDIE-----RGGAK--LIRIRDNGCGIK-KDELALALARHATS 80
Query: 316 KQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFLSQSLNQGKD-NLEIPI 374
K DD I +GF+ A+ LT T+ + Q+ +G+D N+ +
Sbjct: 81 KIASLDDLEAI--ISLGFRGEALASISSVSRLTLTSRTAEQQEAWQAYAEGRDMNVTVKP 138
Query: 375 VSYYRKGQFMELDTVVQSEATAKYNLKSIKEFSPFNKYL 413
++ LD + A K+ EF+ ++ +
Sbjct: 139 AAHPVGTTLEVLDLFYNTPARRKFLRTEKTEFNHIDEII 177
>pdb|2XJJ|A Chain A, Structre Of Hsp90 With Small Molecule Inhibitor Bound
pdb|2XJJ|B Chain B, Structre Of Hsp90 With Small Molecule Inhibitor Bound
Length = 249
Score = 29.6 bits (65), Expect = 6.7, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 293 LSIIDDGHGMTHQDVVR---------MTYFGHKQPDADDPNRIGRFGVGFKTGAMRLGKD 343
L+I+D G GMT D++ F D + IG+FGVGF + A + +
Sbjct: 102 LTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYS-AYLVAEK 160
Query: 344 ALVLTQTADSRSIAFLSQS 362
V+T+ D A+ S +
Sbjct: 161 VTVITKHNDDVQYAWESSA 179
>pdb|1NHJ|A Chain A, Crystal Structure Of N-Terminal 40kd MutlA100P MUTANT
PROTEIN COMPLEX With Adpnp And One Sodium
Length = 333
Score = 29.3 bits (64), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 39/159 (24%), Positives = 70/159 (44%), Gaps = 14/159 (8%)
Query: 259 IAELVDNSRDAKATKLEISIESIYFKKAGKDIPMLSIIDDGHGMTHQDVVRMTYFGH--- 315
+ ELV+NS DA AT+++I IE + G ++ I D+G G+ +D + + H
Sbjct: 29 VKELVENSLDAGATRIDIDIE-----RGGAK--LIRIRDNGCGIK-KDELALALARHATS 80
Query: 316 KQPDADDPNRIGRFGVGFKTGAMRLGKDALVLTQTADSRSIAFLSQSLNQGKD-NLEIPI 374
K DD I +GF+ A+ LT T+ + Q+ +G+D N+ +
Sbjct: 81 KIASLDDLEAI--ISLGFRGEALPSISSVSRLTLTSRTAEQQEAWQAYAEGRDMNVTVKP 138
Query: 375 VSYYRKGQFMELDTVVQSEATAKYNLKSIKEFSPFNKYL 413
++ LD + A K+ EF+ ++ +
Sbjct: 139 AAHPVGTTLEVLDLFYNTPARRKFLRTEKTEFNHIDEII 177
>pdb|1X4I|A Chain A, Solution Structure Of Phd Domain In Inhibitor Of Growth
Protein 3 (Ing3)
Length = 70
Score = 28.9 bits (63), Expect = 9.7, Method: Compositional matrix adjust.
Identities = 20/54 (37%), Positives = 25/54 (46%), Gaps = 4/54 (7%)
Query: 633 GFDTKSLPVEWFCYMKPFEGLCDLPEQKVDAGVVTVSAKRTGYDSRENSLPFEG 686
G D + P+EWF Y GL + P+ K T + KR G SR S P G
Sbjct: 21 GCDNQDCPIEWFHYG--CVGLTEAPKGKWYCPQCTAAMKRRG--SRHKSGPSSG 70
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.319 0.136 0.420
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 22,984,431
Number of Sequences: 62578
Number of extensions: 995785
Number of successful extensions: 2041
Number of sequences better than 100.0: 60
Number of HSP's better than 100.0 without gapping: 0
Number of HSP's successfully gapped in prelim test: 60
Number of HSP's that attempted gapping in prelim test: 1992
Number of HSP's gapped (non-prelim): 62
length of query: 726
length of database: 14,973,337
effective HSP length: 106
effective length of query: 620
effective length of database: 8,340,069
effective search space: 5170842780
effective search space used: 5170842780
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 55 (25.8 bits)